Menu
GeneBe

rs2230162

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_003803.4(MYOM1):​c.999G>A​(p.Gly333=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.305 in 1,590,008 control chromosomes in the GnomAD database, including 75,850 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6642 hom., cov: 32)
Exomes 𝑓: 0.31 ( 69208 hom. )

Consequence

MYOM1
NM_003803.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.828
Variant links:
Genes affected
MYOM1 (HGNC:7613): (myomesin 1) The giant protein titin, together with its associated proteins, interconnects the major structure of sarcomeres, the M bands and Z discs. The C-terminal end of the titin string extends into the M line, where it binds tightly to M-band constituents of apparent molecular masses of 190 kD (myomesin 1) and 165 kD (myomesin 2). This protein, myomesin 1, like myomesin 2, titin, and other myofibrillar proteins contains structural modules with strong homology to either fibronectin type III (motif I) or immunoglobulin C2 (motif II) domains. Myomesin 1 and myomesin 2 each have a unique N-terminal region followed by 12 modules of motif I or motif II, in the arrangement II-II-I-I-I-I-I-II-II-II-II-II. The two proteins share 50% sequence identity in this repeat-containing region. The head structure formed by these 2 proteins on one end of the titin string extends into the center of the M band. The integrating structure of the sarcomere arises from muscle-specific members of the superfamily of immunoglobulin-like proteins. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 18-3176065-C-T is Benign according to our data. Variant chr18-3176065-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 226838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.828 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.311 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYOM1NM_003803.4 linkuse as main transcriptc.999G>A p.Gly333= synonymous_variant 6/38 ENST00000356443.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYOM1ENST00000356443.9 linkuse as main transcriptc.999G>A p.Gly333= synonymous_variant 6/381 NM_003803.4 P2P52179-1
MYOM1ENST00000261606.11 linkuse as main transcriptc.999G>A p.Gly333= synonymous_variant 6/371 A2P52179-2

Frequencies

GnomAD3 genomes
AF:
0.294
AC:
44648
AN:
151996
Hom.:
6633
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.273
Gnomad AMI
AF:
0.266
Gnomad AMR
AF:
0.262
Gnomad ASJ
AF:
0.312
Gnomad EAS
AF:
0.266
Gnomad SAS
AF:
0.304
Gnomad FIN
AF:
0.296
Gnomad MID
AF:
0.229
Gnomad NFE
AF:
0.314
Gnomad OTH
AF:
0.298
GnomAD3 exomes
AF:
0.282
AC:
69539
AN:
246366
Hom.:
10163
AF XY:
0.286
AC XY:
38184
AN XY:
133618
show subpopulations
Gnomad AFR exome
AF:
0.272
Gnomad AMR exome
AF:
0.197
Gnomad ASJ exome
AF:
0.303
Gnomad EAS exome
AF:
0.245
Gnomad SAS exome
AF:
0.300
Gnomad FIN exome
AF:
0.288
Gnomad NFE exome
AF:
0.307
Gnomad OTH exome
AF:
0.292
GnomAD4 exome
AF:
0.306
AC:
440417
AN:
1437894
Hom.:
69208
Cov.:
30
AF XY:
0.306
AC XY:
219367
AN XY:
716216
show subpopulations
Gnomad4 AFR exome
AF:
0.266
Gnomad4 AMR exome
AF:
0.204
Gnomad4 ASJ exome
AF:
0.309
Gnomad4 EAS exome
AF:
0.306
Gnomad4 SAS exome
AF:
0.298
Gnomad4 FIN exome
AF:
0.296
Gnomad4 NFE exome
AF:
0.314
Gnomad4 OTH exome
AF:
0.299
GnomAD4 genome
AF:
0.294
AC:
44698
AN:
152114
Hom.:
6642
Cov.:
32
AF XY:
0.292
AC XY:
21676
AN XY:
74360
show subpopulations
Gnomad4 AFR
AF:
0.273
Gnomad4 AMR
AF:
0.262
Gnomad4 ASJ
AF:
0.312
Gnomad4 EAS
AF:
0.266
Gnomad4 SAS
AF:
0.304
Gnomad4 FIN
AF:
0.296
Gnomad4 NFE
AF:
0.314
Gnomad4 OTH
AF:
0.300
Alfa
AF:
0.307
Hom.:
5994
Bravo
AF:
0.288
Asia WGS
AF:
0.285
AC:
990
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 17, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 24, 2014Gly333Gly in exon 6 of MYOM1: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 31.2% (2585/8296) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2230162). -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 13, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Hypertrophic cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
7.9
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2230162; hg19: chr18-3176063; COSMIC: COSV55288515; API